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Abstract
The interactions of tributyllead with lysosomes from rat liver have been studied. It results that the organometal compound induces a fast
alkalinization in energized lysosomes. The interpretation is that the compound is a potent proton carrier. This function could explain the
toxicity, in particular at neurological level of the compound. Ó 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction with a consequent collapse of the electrochemical po-
tential.
In the last few years the study of the interactions of In order to confirm this mechanism, in this paper we
trialkyl metals with the biological structures have received have studied the interactions of Bu PbCl with lysosomes.3
more and more attention since these compounds are Like mitochondria, lysosomes are sensitive to the presence
involved in many problems of environmental concerns of uncouplers, but, differently from mitochondria, they do
[1–11]. Therefore, the behaviour and the toxic effects of not produce ATP, but utilise ATP to pump protons in the
trialkylmetal compounds have been largely investigated in inner compartment. As a consequence, in lysosomes the
animals, to study toxicological effects, and in cells and internal pH is acid and the potential is low and positive-
subcellular structures in order to explain the molecular inside (in mitochondria the pH is alkaline-inside and the
mechanisms responsible for the effects observed in the potential is high and negative-inside). Furthermore, lyso-
whole organism. somes are less complex systems than mitochondria since
The molecular interactions of R PbCl with mitochondria the respiratory chain which interferes with trialkyllead3
have been largely studied [1–3] and a model has been compounds and proteic channels pore [12] are absent.
proposed which suggests that these compounds act as Therefore, lysosomes are a good test to confirm the
2 2Cl /OH exchanger: leadtrialkyls enter the mitochondrial already proposed uncoupling mechanism.
membrane as R PbCl and are extruded as R PbOH, thus We have chosen the tributyllead derivative since it is the3 3
giving rise to a cyclic mechanism which explains some most toxic for animals and the most destructive for cells
aspects of the toxicity of these compounds. [4,11].
Recently, a new model has been proposed to explain the
interactions of R PbCl with mitochondria [6]. The authors3
1propose that the system R Pb /R PbOH is an uncoupler 2. Materials and methods3 3
(protons carrier) of oxidative phosphorylation: R PbCl3
1
enter mitochondria as aquo-cations R Pb and are ex- Lysosomes from rat liver have been prepared following3
truded as R PbOH. The consequent cyclic mechanism the procedure indicated by Savant et al. [13]. The protein3
gives rise to a transport of protons through the membrane concentration has been determined by the Lowry method
[14]. The lysosomes, after the last centrifugation of the
preparation, have been resuspended in a medium con-
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08C. The protein concentration of the resuspended lyso-
somes was 20 mg/ml. The dye acridine orange (AO) 1.0
mM in ethanol was used.
Acridine orange uptake by lysosomes was followed
spectrophotometrically at 208C by a Jenway 6400 Spec-
trophotometer at 492 nm. After addition to the medium
(2.5 ml) operating of 20 ml of lysosomes and 20 ml dye
AO (1 mM) before the addition of 2 mM ATP, the
instrument was calibrated at zero absorbance.
1The rates of H efflux from energised lysosomes after
addition of NH , bafilomycin, duramycin, FCCP or3
Bu Pb–Cl were calculated assuming an internal volume of3
lysosomes of 4 ml /mg lysosomal protein [15] and from the
slope of the plot. Absorbance changes against time when
the compound is added Fig. 1. Acidification of lysosomes in a KCl medium and alkalinization
All reagents were of analytical grade. p-Trifluoro- induced by Bu PbCl (0.8 mM), FCCP (0.5 mM), NH (10 mM),3 3
bafilomycin (50 nM), duramycin (10 mg/100 mg protein). The arrowsmethoxycarbonyl cyanide phenylhydrazone (FCCP), Ac-
indicate the points of addition of the compounds. Lysosomes are acidifiedridine Orange and Bu PbCl were supplied by FLUKA3 by addition of 2 mM ATP in the incubating medium (2.5 ml). Medium
composition: 0.125 M KCl, 20 mM Hepes pH 7.4, 2.5 mM MgCl , 5002
mM EGTA and 8 mM AO. Lysosomes 0.2 mg/ml. Before ATP addition
3. Results and discussion the instrument was calibrated at zero absorbance at a fixed wavelength
(492 nm). (a) The alkalinization induced by addition of 0.8 mM Bu PbCl3
(trace 1, full line) or 0.5 mM FCCP (trace 2, dotted line) is shown. (b)In lysosomes, the ATP-dependent proton pump (vac-
1 The alkalinization induced by addition of 10 mM NH as (NH ) SO3 4 2 4uolar-type H ATPase) pumps the protons into the matrix. (trace 1), 50 nM bafilomycin (Baf) (trace 2), 10 mg/100 mg proteinSince the membrane is not permeable to protons, their duramycin (Dur)(trace 3) is shown. The addition of duramycin gives rise
influx gives rise to acidification and, as consequence, to a to a small absorbtion which has been subtracted from the figure. Traces 4
and 5 refer to the alkalinization induced by organolead (0.8 mM) andpositive potential in the internal matrix. The positive-inside
FCCP (0.5 mM), respectively.potential opposes to a marked acidification since the
2protons are positively charged. In the presence of Cl ions
in the suspending medium, the presence of a positive- massive doses of weak permeant base [15,18–20], above
2inside potential induces the uptake of Cl ions through a millimolar concentration. This is not the case of Bu PbCl,3
selective channel [16]. As a consequence of the uptake of the effect of which occurs below micromolar concen-
these negative ions, the internal potential collapses and the tration.
pH decreases from 5.2 [17] to about 4.5 [16,17]. The (ii) Internal alkalinization arises from inhibition of the
acidification in lysosomes is easily followed by the dye proton pump. As Fig. 1b (trace 2) shows, the addition of
(AO) [18]. This dye is a weak base and following the bafilomycin, a potent inhibitor of the vacuolar ATPase [21]
behaviour of permeant weak bases [16], it crosses the causes a proton efflux, but this efflux rate is very slow (2 p
1
membrane as electroneutral compound and is accumulated moles H /mg protein /min) if compared to that obtained
1(and more concentrated) in the internal matrix due to the by addition of Bu PbCl (16.8 p moles H /mg protein /3
more acid pH inside the membrane. This accumulation min, trace 4). Therefore, even if Bu PbCl would inhibit the3
gives rise to a quenching of the absorption spectrum. vacuolar ATPase, the very fast observed alkalinization
Therefore, as Fig. 1a shows, the internal acidification can cannot be due to this inhibitory effect.
be followed by absorbance quenching at a fixed wave- (iii) Alkalinization of internal pH may arise from
length (492 nm) [18]. About 20 min after ATP energiza- inhibition of the chloride channel. As Fig. 1b (trace 3)
tion, a steady state is reached in which the internal pH is shows, the addition of duramycin, a potent inhibitor of the
about 4,5 and the internal potential is very low (about 120 chloride channel [22] does not induce an appreciable fast
2 1
mV) [15] when the medium contains 0.125 M Cl . In release of protons from the internal matrix (H efflux rate:
1these conditions the addition of Bu PbCl causes a fast 0.8 p moles H /mg protein /min). Therefore, the fast3
increase in absorbance of AO, thus indicating internal alkalinization induced by Bu PbCl cannot be due to an3
alkalinization (Fig. 1a) which in energized lysosomes can inhibition of the chloride channel of lysosomes.
be due to many effects. (iv) Uncouplers are proton carriers and, as Fig. 1a shows
(i) Weak permeant bases such as ammonia, are rapidly (trace 2), the addition of FCCP, a potent proton carrier,
1
accumulated in the internal acid matrix [16] and the causes a fast proton release (H efflux rate: 15.2 p moles
1
accumulation enhances the internal pH (Fig. 1b), trace 1; H /mg protein /min) from the lysosomal matrix.
1 1 1the calculated rate of H efflux is 60 p moles H /mg Since the same effect is induced by Bu PbCl (H efflux3
1protein /min). This effect, however, is induced only by rate: 23.2 p moles H /mg protein /min, Fig. 1a, trace 1),
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this behaviour suggests the possibility that Bu PbCl, like induced by Bafilomycin (trace 1), Bu Pb–Cl (trace 2) and3 3
1FCCP acts as a potent proton carrier. The same behaviour FCCP (trace 3) are 0.8, 12 and 10 p moles H /mg
has been already proposed to explain the interaction of protein /min respectively) and in the absence of
1trialkyllead chlorides with mitochondria [6]. bafilomycin (Fig. 2a); the H efflux rates for Bu Pb–Cl3
In mitochondria, however, another mechanism has been (trace 1) and FCCP (trace 2) are 10.8 and 9.2 p moles
1proposed to explain the interactions of R MCl (M5metal, H /mg protein /min respectively), a potent inhibitor of the3
2 2R5alkyl) with the membrane and in particular the toxicity vacuolar pump. In this case, the mechanism of Cl /OH
2
of trialkyllead compounds [1–3]. This mechanism pro- exchange cannot be proposed since Cl is absent from the
poses that trialkylmetals enter mitochondria as R MCl medium.3
electroneutral compounds and are extruded as R MOH The results therefore support the hypothesis that3
compounds, thus giving rise to a cycling mechanism in Bu PbCl behaves as uncoupler, by enhancing the proton3
2 2
which the starting compound acts as Cl /OH exchanger. permeability in the biological membrane. This mechanism
This mechanism can be applied to lysosomes to explain the (which however does not exclude the other possibility)
experimental behaviour of Fig. 1: in this case the com- implies that Bu PbCl enters the lysosomal membrane as3
pound should enter as Bu PbOH since the pH is more acid electroneutral compound Bu PbOH. In order to justify this3 3
2inside, but, being Cl also accumulated inside, the hypothesis, the following solvolytic and hydrolytic equilib-
Bu PbCl compound is extruded. ria of Bu PbCl species in aqueous solution must be3 3
In order to distinguish between the two mechanisms, we considered [23,24]:
have carried out the experiments of Fig. 2 in a medium
1 2Bu PbCl ~ Bu Pb 1 Cl3 (aq) 3 (aq)containing the potassium carrier valinomycin [18], and in
1 1the absence of chloride ions. Since lysosomes contain in Bu Pb 1 2H O ~ Bu PbOH 1 H O3 (aq) 2 3 (aq) 3
the matrix about 0.1 M potassium, the presence of val-
1inomycin allows the extrusion of potassium ions from the Bu Pb behaves as a weak acid (pK 59.1 [24]) and at pH3 a
1internal matrix to the external medium. As one can see 7.4 the ratio [Bu Pb ] / [Bu PbOH] is about 50. Therefore,3 3
(Fig. 2), the addition of ATP induces acidification of the even if in a very small amount, the hydroxide is always
matrix. When valinomycin (Val) is added, the acidification present and its uptake is favoured by the acid conditions
2 1
rises and the behaviour is the same as that due to the Cl inside the membrane. Once inside, Bu Pb species is3
uptake showed in Fig. 1: the positive-inside potential formed and is extruded as lipophilic cation. The balance of
1induced by ATP addition collapses by K extrusion and the whole cyclic mechanism is the transport of a proton
2
not by Cl uptake, thus allowing the pH to rise to a more through the membrane as in the case of the uncoupling
acid value. Bu PbCl and FCCP behave in the same mechanism. The extrusion is caused by the proton pump3
1
manner, both in the presence (Fig. 2b) (the H efflux rates which induces the positive-inside potential with con-
1
sequent extrusion of the lipophilic cation Bu Pb . It has3
1
already been demonstrated that the cation Bu Pb is3
carried through the membrane by a potential-driven mech-
anism [6]. The same behaviour has been observed with
respect to the interaction of trialkyltin compounds with
mitochondria [11] and lysosomes [25,] since also these
compounds are weak acids and lipophilic.
It cannot be excluded, however, that Bu PbCl, like other3
organometal compounds, inhibit the vacuolar ATPase [26]
(this study is not the aim of this paper). But, if this is the
case, the effects observed after addition of Bu PbCl or3
bafilomycin (the inhibitor of ATPase) to the matrix should
be similar. The experiments of Fig. 2b, show clearly that
this is not true: the alkalinization induced by the or-
ganolead is faster than that caused by the bafilomycin.
In order to exclude the possibility of a competitive2Fig. 2. Acidification of lysosomes in a Cl free medium and alkaliniza- ATPase inhibitory effect between Bafilomycin and Bu Pb–3tion induced by 8 mM Bu PbCl, 0.1 mM FCCP and 50 nM bafilomycin3 Cl, we have operated in the presence of varying amountsafter Valinomycin (Val) (18 mM) addition. The arrows indicate the points
of addition of the compounds. Lysosomes are acidified by ATP 2 mM of Bafilomycin. The results (not shown) indicate that even
added in the incubating medium. Medium composition: 100 mM sucrose, if a dose of 500 nM (instead of 50 nM) of Bafilomycin is
50 mM K SO , 20 mM Hepes pH 7.4, 2.5 mM MgSO , 500 mM EGTA,2 4 4 employed, the alkalinization rate induced by Bafilomycin
8 mM AO. (a) The alkalinization induced by addition of 8 mM Bu PbCl3 alone and by 500 nM Bafilomycin plus Bu Pb–Cl (0.8 mM3(trace 1) or 0.1 mM FCCP (trace 2) is shown. (b) The alkalinization
in Fig. 1, trace 4, or 8 mM in Fig. 2, trace 2) is identical.induced by addition of 50 nM Bafilomycin (Baf) (trace 1), and of 8 mM
Bu PbCl (trace 2) and of 0.1 mM FCCP (trace 3) is shown. This behaviour demonstrate that 50 nM Bafilomycin3
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